Save up to $400 Off - Ends August 5

Learning from the Tech Boom

In this session, the audience will hear from a successful entrepreneur from a mainstream industry that understands the ebbs and flows of a new field and how to adjust accordingly.  In this session, you will gain insights on:  How to create a flexible business that can adapt to abrupt market changes  What to do when capital dries up and prepare for the inevitable  […]

Read More…

Breaking into Inter-European Trade

Currently there are only a handful companies exporting medical marijuana to Europe or across borders in Europe. As Canadian companies struggle with imports into Europe, what can your company do to become the next exporter?   In this session, you will gain insights on:  Regulations regarding inter-European trade of cannabis  What changed (or didn’t) in the past year  How compliance […]

Read More…

Lessons Learned from North America

The US and Canadian markets are significantly more developed than the European markets, but after a period of irrational exuberance, the past few months have been challenging. What can the European industry learn from their North American counterparts’ mistakes?  In this session, you will gain insights on:  The current challenges of seeking capital and raising funds  How to prepare […]

Read More…

Novel Food Directive: What It Means for Your Company

The European Commission updated the “novel foods” catalog to include derived products containing cannabinoids, which, in turn, means CBD products to be sold as food must be undergo a pre-marketing authorization.  In this session, you will gain insights on:  Understanding the time and resource consuming process for approval  Which products can commercialized without EC authorization   The risks of noncompliance  […]

Read More…

In Focus: Denmark’s Pilot Program

Denmark’s four-year medical cannabis trial program launched in January 2018 with its focus on patients and treating with dignity. The program has not been without its challenges. This session will examine the program two years later including ongoing research and lessons learned.  In this session, you will gain insights on:  How the government is evaluating the program  The potential for an extension of the trial  […]

Read More…

The Lynchpin: European GMP and Compliance

Following GMP guidelines and maintaining compliance in an ever-evolving industry is the key to success for the medical cannabis industry in Europe and around the world.   In this session, you will gain insights on:  Effective strategies to staying compliant in an evolving market  Best ways to manage your bottom line considering costly compliance changes  Other compliance issues that go beyond obtaining EU-GMP certification […]

Read More…

State of the Industry

Without the hype or doom, this session will cover what’s happened in the global and European markets since the European Symposium last year. It will examine the trends that have impacted the industry, including the trends in the North American markets, novel food authorization, and major moves made by Canadian companies.   In this session, you will gain insights on:  WHO cannabis scheduling recommendations  The current state of the […]

Read More…